By Reuters
NYT U.S.
Drugmaker Eli Lilly & Co said on Tuesday it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the United States, many of whom are facing financial difficulties due to the coronavirus outbreak.
Published date: April 7, 2020 at 01:45PM
Reuters
New York Times article
No comments:
Post a Comment